ImmunityBio Inc. (NASDAQ:IBRX) traded at $6.06 at close of the session on Friday, 09/16/22, made a downward move of -5.75% on its previous day’s price.
Looking at the stock we see that its previous close was $6.43 with the day’s price range being $5.52 – $6.26. In terms of its 52-week price range, IBRX has a high of $10.88 and a low of $2.60. The company’s stock has gained about 40.60% over that past 30 days.
ImmunityBio Inc. has a market cap of $2.57 billion. Estimates by analysts give the company expected earnings per share (EPS) of $0, with the EPS growth for the year raised at -$0.9 for 2022 and -$0.8 for next year. These figures represent -1.10% and 11.10% growth in EPS for the two years respectively.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at $20k, with a low of $20k and a high of $20k. The median projection represents growth adding up to -94.10% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for 2022 is expected to hit $90k, or -90.40% down from figures reported last year.
There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the IBRX stock, short term indicators assign the stock an average of 50% Buy, while medium term indicators assign it an average of Hold. Long term indicators on average place the stock in the category of 50% Buy.
Looking further, we note the current price level is 33.04% off its SMA20 and 36.47% from its 50-day simple moving average. The RSI (14) is pointing at 68.92 while the volatility over the past week is 17.10% and jumps to 10.02% over the past one month. The beta value is 1.63, while the average true range (ATR) is currently pointing at 0.53.
Coming back to ImmunityBio Inc. (NASDAQ:IBRX), we note that the average 3-month trading volume was 1.59 million, while that of the preceding 10-day period stands at 3.64 million. Current shares outstanding are 397.99 million.
The insiders hold 79.61% of the company’s shares while institutions hold 8.70%. The data shows that short shares as of Jul 14, 2022, stood at 18.46 million at a short ratio of 8.96. This represents a 4.64% short interest in shares outstanding on Jul 14, 2022. Shares short fall in July from the previous month at 19.27 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -0.33% down in year-to-date price movement.